Page last updated: 2024-09-02

ci 988 and fg 7142

ci 988 has been researched along with fg 7142 in 2 studies

Compound Research Comparison

Studies
(ci 988)
Trials
(ci 988)
Recent Studies (post-2010)
(ci 988)
Studies
(fg 7142)
Trials
(fg 7142)
Recent Studies (post-2010) (fg 7142)
147814415148

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Field, MJ; Hughes, J; Menzies, R; Oles, RJ; Singh, L; Vass, CA; Woodruff, GN1
Boyce, S; Rupniak, NM; Webb, JK1

Other Studies

2 other study(ies) available for ci 988 and fg 7142

ArticleYear
The behavioural properties of CI-988, a selective cholecystokininB receptor antagonist.
    British journal of pharmacology, 1991, Volume: 104, Issue:1

    Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Behavior, Animal; Benzodiazepinones; Carbolines; Central Nervous System Depressants; Cholecystokinin; Conflict, Psychological; Devazepide; Drug Interactions; Ethanol; Hypnotics and Sedatives; Indoles; Injections, Intraventricular; Male; Meglumine; Mice; Motor Activity; Pentagastrin; Pentobarbital; Pentylenetetrazole; Phenylurea Compounds; Postural Balance; Rats; Receptors, Cholecystokinin; Social Behavior

1991
Inhibition of pentagastrin-induced pressor response in conscious rats by the CCK-B receptor antagonist CI-988 and chlordiazepoxide.
    Regulatory peptides, 1996, Jan-16, Volume: 61, Issue:1

    Topics: Animals; Blood Pressure; Carbolines; Chlordiazepoxide; Hormone Antagonists; Indoles; Male; Meglumine; Pentagastrin; Rats; Rats, Sprague-Dawley; Receptor, Cholecystokinin B; Receptors, Cholecystokinin

1996